Introduction
Heterocyclic compounds have occupied a prominent place among various classes of organic compounds by virtue of their diverse biological activities. Hence the design, synthesis and production of new molecules for crop health and human welfare have taken center stage in recent years. Among the wide variety of heterocyclics that have been explored for developing pharmaceutically important role in medicinal chemistry [1] .
Benzimidazole and its derivatives are of great importance in medicinal chemistry because of their wide variety of biological and pharmacological applications [1, 2] . The literature survey shows several examples of compounds having a benzimidazole ring which exhibit remarkable bioactivity that could make them potentially useful in the treatment of cancer, and cardiovascular diseases [3] . The benzimidazole unit and it's derivatives possess anticancer [4] , antiinflammatory [5] , antibacterial [6] , antifungal [7] , antidiabetic [8] , and anti-HIV activities [9] . On the basis of this observation we have synthesized benzimidazole derivatives as hitherto unreported analogues.
Literature survey has also revealed the importance of benzimidazoles as antimicrobial and antioxidant agents [10] [11] [12] [13] [14] . It has also been reported that certain substituted benzimidazole derivatives have a broad antimicrobial spectrum [11] . Motivated by this above-mentioned facts herein is reported the synthesis and antimicrobial, anti oxidant activities of new benzimidazole series.
Experimental

Instrumentation
All the reagents were purchased from Aldrich Chemicals Co, Loba Chemie. All the solvents and reagents used for the synthesis and analysis were of analytical grade. The progress of the reaction and the purity of the compounds were checked by thin layer chromatography (TLC). 1 H NMR spectra were recorded on a BRUKER-AV400 spectrometer in CDCl3 and tetramethylsilane (TMS; δ = 0.00 ppm) served as internal standards. IR spectra were measured using a JASCO FT/IR-4100 spectrometer. Mass spectra were measured with Micromass Q-Tof. CHNS were measure by the Elementar Vario EL III (Germany). Thin-layer chromatography was carried out using SILICA GEL GF254. The melting points (uncorrected) were measured on a SALACO apparatus. 
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1-(Phenoxycarbonyloxy
)ethyl-2-ethoxy-1-((2'-(1-(phenyl sulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl) methyl)-1H-benzo[d] imidazole
1-(Phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(2-nitro phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1-(Phenoxycarbonyloxy)ethyl 1-((2'-(1-(2,5-dichlorophenyl sulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-(phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(3-nitro phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-
1-(Phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-tosyl-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1-(Phenoxycarbonyloxy)ethyl 1-((2'-(1-(4-chlorophenyl sulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
1-(Phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(3-(trifluoro methyl) phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1-(Phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(4-fluoro phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
1-(Phenoxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(2-fluoro phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
Biological evaluation -antibacterial and antioxidant activity studies
Antibacterial activity
Antibacterial tests were carried out by disc diffusion method using 100 µL of suspension containing 10 6 cells/mL of bacteria. The discs (6 mm diameter) were impregnated with 5 mg and 10 mg/mL of each compound and placed on the inoculated nutrient agar. Then, the inoculated plates were incubated at 37±0.1 o C at 24 h. One antibacterial drug, chloramphenicol, also is used as positive control. Antibacterial activity was evaluated by measuring the zone of inhibition against the test organisms.
Antioxidant activity
The DPPH assay was done by using solution of each compound made in methanol was added to 95 µL of DPPH solution (0.2 mM/mL methanol) and mixed vigorously. The mixture was incubated in dark at room temperature for 30 min. Absorbance was measured at 517 nm using an Elisa reader. 
where AC is the absorbance of the control and A is the absorbance of sample. Percentage scavenging was also evaluated in ascorbic acid equivalence.
Results and discussion
We have synthesized a series of 1-(phenoxy carbonyloxy)ethyl 2-ethoxy-1-((2'-(1-(phenylsulfonyl)-1H-tetrazol-5-yl) biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate derivatives using a known procedure and obtained products with good yield.
The structures of all the synthesized compounds were characterized by spectroscopic data, and allowed these molecules for study of antibacterial and antioxidant activities (Table 1 and 2). Benzimidazole derivatives shows a very good anti bacterial activities [10] [11] [12] [13] [14] , we are comparing the synthesized new benzimidazole derivatives to the marketed chlorophenicol [15] which shows very good anti bacterial activity, here we are synthesizing the newly substituted benzimidazole derivatives for the studies of antibacterial activities by comparison with the drug molecule. In this studies compound 3f shows good bacterial activity, in which the tertiary butyl group is the electron releasing group, which is attached to the para position. The compound 3i shows least antibacterial activity, in which the fluoro group is attached to the para position, which is the electron withdrawing group. The remaining molecules showing the moderate activity.
The synthesized compounds were tested for anti oxidant activities by evaluation with ascorbic acid [16, 17] . In antioxidant studies the compound 3h shows the good antioxidant activity, in which the trifluoro methyl group is attached to the meta position which is highly electron withdrawing. Compound 3a shows the least antioxidant activity, which does not having any substitution. 
Conclusion
The structure proposed of the synthesized compound is well supported by spectroscopic data. From the data of antibacterial activity and antioxidant activity, it may be concluded that all the synthesized compounds possess good to moderate activity.
